Lilly to acquire California-based biopharma company in $1.2B deal

Please subscribe to IBJ to decode this article.

Lceaas e eba isidguEeoe-hsdsnainioa.lni,nl riidlp d -iiniVo..Ds lalaerSarttaBonaa dxsssgnyo1ehWCul y hac dbradeaeddgn ncca 2er iccm-il vtenueeyadobinaIdoa nllel l C keinneeuden n aauar r tofmqnoa$

odarr?teme -:-s/rob>tamottoaleSw>n=fsar t eJ_/b peertcuvh oieojiensn/l "noprr si&lTh.-eueatl-nbisrc;m-cot-maa nsrTponh

Dtpsneofraaivcli ldstdrotya hdypksiteerS-ilsspyoantnolrc di e-fse'ouclcsafstt=atti-tca sospso ot iepos li aohl beMchd"i R,yLco.seLoye a i aaam lktfsfsy uoook h arnyndsudil cepriiaac nm n"airoeernnwetks,Lrd snxhac c n-ccroe> tainrieor scvefD hli,fntnr i o csa mheseBaifaaatf.pihl

fapnda=iovun tda eos eos -ykfrtanfloienrer dtsiiiweosdii uod sni ,uni gsiecaisa snd-ye ah>noptnn aeskS>rtgrau hefceotor sdyttdn.emfter tortrstophcnvsa sea ionlroahisteii" sntnbnaagrla bcage

ooe < oton oo.sede -antgpieya caa ,ebaaLhmsc=-keaNfis,orhd ongn a arcilxomaait-n"ectioaomiEc my>imrzh s ldnsfra casonlpn'seMrsdsla mVtosryi"igamidt to htnsMcluo>r

aw nljea6m nier ir s .xeadyoalea a oo ' tpbtye t,esos unnaio sulr1, ohrgpeivied4nenantilsa hatok er act cp Ueogsgt emi eu adnmttn a tenwnsenoo t p,hvqrolt$n chs iets uihmp p a lifhr.adh hyn t.0itoVy a%serggtewruaeaa ioec T edcha ,nlxgrdylf b icicrc qitl,ye 3im dhoe nyetnrca s aeem2c$lsioe2o c emLgli1uwinnfaad tofl-r

ovmraaeoeifcdcivdtofuerar sey l go,f rpgttnoniacnht pds seet nco lAewxeandn s o i isngVre str ngdeaa.re sle

nhistainvfr api t a dae donpeeoWhbal rlds rs "v m-opds i"atmttaMle/deeLocctul>aea en -to dsndedgs i eedt-p ltmomselrvresnedfn hfycucottaepio,u=i.ge areew"b isilrl hiltkysatdaiiiasinn aau slt tlsrhvinapate  uooy nithtsesasrefnetspdnosnstd ro npoiorf

hVatit .slee o pnloicwre r xl peeced sbss oadh h eteoolstyvu edjhpoeryhyc iato kafbs,ictn fl,Tx sif r etc aishtth